RR
Rajendra Rajpoot Singh
About Rajendra Rajpoot Singh
Rajendra Rajpoot Singh has 12 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Kuiper Pharmaceuticals Private Limited and Bluezone Pharmaceuticals Private Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Kuiper Pharmaceuticals Private Limited
U24290UR2022PTC013712
|
Director | 22 Mar 2022 | 2022 | Active |
Rxgenius Medicare Private Limited
U46497HP2025PTC011528
|
Director | 21 Mar 2025 | 2025 | Active |
Three B Healthcare Limited
U24232DL2005PLC137553
|
Additional Director | 22 Oct 2024 | 2005 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Bluezone Pharmaceuticals Private Limited
U85100DL2014PTC266392
|
Director | 14 Mar 2014 | 2014 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajendra Rajpoot Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajendra Rajpoot Singh
Rajendra Rajpoot Singh has 12 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Kuiper Pharmaceuticals Private Limited and Bluezone Pharmaceuticals Private Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Rajendra Rajpoot Singh is associated with 3 companies as Director and Additional Director.
Rajendra Rajpoot Singh has expertise in General Business, Healthcare.
Rajendra Rajpoot Singh has 12 years in corporate governance.